Cobalt Defense Nixed In Suit Over Generic Boniva

Law360, New York (December 20, 2010, 3:21 PM EST) -- A federal judge has dealt a blow to Cobalt Pharmaceuticals Inc. in a legal battle brought by Hoffmann-La Roche Inc. over a generic version of bone-loss drug Boniva, ruling that Cobalt's defense based on the completeness of the patent application does not work.

Though Roche may have included the wrong inventors on its patent application, that does not render the patent invalid, Judge Stanley Chesler of the U.S. District Court for the District of New Jersey ruled Friday. The ruling grants a Roche motion for summary...
To view the full article, register now.